STERIS plc (STE)

New York Stock Exchange:
STE
| Latest update: Oct 15, 2025, 6:57 PM

Stock events for STERIS Plc (Ireland) (STE)

In the past six months, STERIS Plc's stock experienced several notable events. For fiscal year 2025, STERIS reported a 6% revenue increase, reaching $5.5 billion, with diluted EPS rising to $6.16. In Q1 2026, the company reported EPS of $2.34, beating estimates, and revenue grew 9% to $1.39 billion, surpassing forecasts. The quarterly dividend was increased by 10% to $0.63. The stock price increased by 14.06% over the past six months, reaching a 52-week high of $253.03. As of September 30, 2025, the share price was $247.41, an increase of 2.01% from September 30, 2024. STERIS stock has received a consensus 'buy' rating from analysts.

Demand Seasonality affecting STERIS Plc (Ireland)’s stock price

The provided search results do not contain specific information regarding the demand seasonality for STERIS Plc's products and services. However, the company's business model, which includes recurring revenue from service contracts, consumable products, and ongoing maintenance agreements, suggests a relatively stable demand. The consistent healthcare spending and increasing demand for sterilization and disinfection products also contribute to a stable outlook.

Overview of STERIS Plc (Ireland)’s business

STERIS Plc is a global medical equipment company specializing in infection prevention and other procedural products and services, operating primarily within the healthcare, life sciences, and medical device industries. The company aims to help customers create a healthier and safer world by providing innovative healthcare and life science products and services globally. Its offerings include capital equipment like surgical tables and sterilizers, consumable products such as endoscopy accessories and detergents, services like equipment maintenance and laboratory testing, and applied sterilization technologies (AST) providing contract sterilization and testing services.

STE’s Geographic footprint

STERIS Plc has a significant global presence with operations in North America and Latin America. The company operates directly in 18 countries and works with distribution partners in over 100 countries. While operationally headquartered in Mentor, Ohio, U.S., STERIS Plc is legally registered in Dublin, Ireland, for tax purposes since 2018.

STE Corporate Image Assessment

STERIS maintains a strong reputation for quality and innovation, supported by its position as a global leader in infection prevention, sterilization, and surgical technologies. The company actively invests in research and development, with 37 new product launches and 672 active patents reported in 2023. Recent events contributing to its reputation include new product introductions, additional disinfectant and virucidal activity claims for its CIP 200 Acid-Based Cleaner and Disinfectant, industry recognition such as the 2022 Pharma Innovation Awards, and expanded services through Extractables and Leachables testing and the acquisition of Cantel Medical. No significant negative events impacting STERIS Plc's brand reputation in the past year were found.

Ownership

STERIS Plc features a mixed ownership structure, with a significant portion held by institutional investors. Institutional investors own approximately 93.22% to 93.65% of STERIS plc stock, with largest shareholders including Vanguard Group Inc., BlackRock Inc., Massachusetts Financial Services Co /ma/, State Street Corp, Morgan Stanley, Generation Investment Management Llp, and Geode Capital Management, Llc. Individual investors hold around 4.88% to 5.85% of shares, while insiders own approximately 0.93% to 0.94% of the shares.

Expert AI

Show me the sentiment for STERIS Plc (Ireland)
What's the latest sentiment for STERIS Plc (Ireland)?

Price Chart

$237.81

4.04%
(1 month)

Top Shareholders

The Vanguard Group, Inc.
12.39%
BlackRock, Inc.
8.80%
Sun Life Financial, Inc.
5.34%
State Street Corp.
4.26%
Morgan Stanley
3.93%
Generation Investment Management LLP
3.23%
Geode Holdings Trust
2.52%
Thalia Street Partners LLC
2.14%
Allan & Gill Gray Foundation
2.10%
Select Equity Partners LP
2.09%
UBS Group AG
1.72%
Stichting Pensioenfonds ABP
1.60%
Janus Henderson Group Plc
1.50%
Franklin Resources, Inc.
1.46%
Mitsubishi UFJ Financial Group, Inc.
1.42%
Virtus Investment Partners, Inc.
1.37%
Government of Norway
1.26%
Invesco Ltd.
1.24%
Principal Financial Group, Inc.
1.17%
Pictet & Partners
1.12%

Trade Ideas for STE

Today

Sentiment for STE

News
Social

Buzz Talk for STE

Today

Social Media

FAQ

What is the current stock price of STERIS Plc (Ireland)?

As of the latest update, STERIS Plc (Ireland)'s stock is trading at $237.81 per share.

What’s happening with STERIS Plc (Ireland) stock today?

Today, STERIS Plc (Ireland) stock is down by -4.04%, possibly due to news.

What is the market sentiment around STERIS Plc (Ireland) stock?

Current sentiment around STERIS Plc (Ireland) stock is positive, based on recent news, trading volume, and analyst opinions.

Is STERIS Plc (Ireland)'s stock price growing?

Over the past month, STERIS Plc (Ireland)'s stock price has decreased by -4.04%.

How can I buy STERIS Plc (Ireland) stock?

You can buy STERIS Plc (Ireland) stock through any brokerage platform, such as e.g., Robinhood, Fidelity, E*TRADE, by searching for the ticker symbol STE

Who are the major shareholders of STERIS Plc (Ireland) stock?

Major shareholders of STERIS Plc (Ireland) include institutions such as The Vanguard Group, Inc. (12.39%), BlackRock, Inc. (8.80%), Sun Life Financial, Inc. (5.34%) ... , according to the latest filings.